serw-MX  [xml]  

 DeCS Categories

C04 Neoplasms .
C04.445 Hamartoma .
C04.445.622 Pallister-Hall Syndrome .
C04.588 Neoplasms by Site .
C04.588.614 Nervous System Neoplasms .
C04.588.614.250 Central Nervous System Neoplasms .
C04.588.614.250.195 Brain Neoplasms .
C04.588.614.250.195.885 Supratentorial Neoplasms .
C04.588.614.250.195.885.500 Hypothalamic Neoplasms .
C04.588.614.250.195.885.500.299 Pallister-Hall Syndrome .
C05 Musculoskeletal Diseases .
C05.660 Musculoskeletal Abnormalities .
C05.660.585 Limb Deformities, Congenital .
C05.660.585.600 Polydactyly .
C05.660.585.600.374 Pallister-Hall Syndrome .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.211 Brain Neoplasms .
C10. Supratentorial Neoplasms .
C10. Hypothalamic Neoplasms .
C10. Pallister-Hall Syndrome .
C10.228.140.617 Hypothalamic Diseases .
C10.228.140.617.477 Hypothalamic Neoplasms .
C10.228.140.617.477.299 Pallister-Hall Syndrome .
C10.551 Nervous System Neoplasms .
C10.551.240 Central Nervous System Neoplasms .
C10.551.240.250 Brain Neoplasms .
C10.551.240.250.700 Supratentorial Neoplasms .
C10.551.240.250.700.500 Hypothalamic Neoplasms .
C10.551.240.250.700.500.249 Pallister-Hall Syndrome .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.131 Congenital Abnormalities .
C16.131.077 Abnormalities, Multiple .
C16.131.077.690 Pallister-Hall Syndrome .
C16.131.621 Musculoskeletal Abnormalities .
C16.131.621.585 Limb Deformities, Congenital .
C16.131.621.585.600 Polydactyly .
C16.131.621.585.600.374 Pallister-Hall Syndrome .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.543 Membrane Proteins .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.705 Receptors, Immunologic .
D12.776.543.750.705.816 Receptors, Antigen .
D12.776.543.750.705.816.824 Receptors, Antigen, T-Cell .
D12.776.543.750.705.816.824.800 Receptor-CD3 Complex, Antigen, T-Cell .
D23 Biological Factors .
D23.050 Antigens .
D23.050.301 Antigens, Surface .
D23.050.301.264 Antigens, Differentiation .
D23.050.301.264.894 Antigens, Differentiation, T-Lymphocyte .
D23.050.301.264.894.095 CD3 Complex .
D23.050.301.264.894.095.800 Receptor-CD3 Complex, Antigen, T-Cell .
D23.101 Biomarkers .
D23.101.100 Antigens, Differentiation .
D23.101.100.894 Antigens, Differentiation, T-Lymphocyte .
D23.101.100.894.095 CD3 Complex .
D23.101.100.894.095.800 Receptor-CD3 Complex, Antigen, T-Cell .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.914 Sequestering Agents .
D27.505.519.914.500 Chelating Agents .
D27.720 Specialty Uses of Chemicals .
D27.720.832 Sequestering Agents .
D27.720.832.500 Chelating Agents .
 Synonyms & Historicals
CD3 Complex .
CD3 Antigen .
T3 Antigen .
T3 Complex .
Antigen, CD3 .
Antigen, T3 .
Antigens, T3 .
CD3 Antigens .
Antigens, CD3 .
T3 Antigens .
Complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL). The CD3 complex includes the gamma, delta, epsilon, zeta, and eta chains (subunits). When antigen binds to the T-cell receptor, the CD3 complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 gamma and delta chains (subunits) are separate from and not related to the gamma/delta chains of the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA). .
Receptor-CD3 Complex, Antigen, T-Cell .
Complex, TCR-CD3 .
T Cell Antigen Receptor CD3 Complex .
TCR CD3 Complex .
T-Cell Antigen Receptor-CD3 Complex .
TCR-CD3 Complex .
Molecule composed of the non-covalent association of the T-cell antigen receptor (RECEPTORS, ANTIGEN, T-CELL) with the CD3 complex (CD3 COMPLEX). This association is required for the surface expression and function of both components. The molecule consists of up to seven chains: either the alpha/beta or gamma/delta chains of the T-cell receptor, and four or five chains in the CD3 complex. .
Chelating Agents .
Chelators .
Metal Chelating Agents .
Agents, Chelating .
Agents, Metal Chelating .
Antagonists, Metal .
Chelating Agents, Metal .
Complexons .
Metal Antagonists .
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. .
Pallister-Hall Syndrome .
CAVE Complex .
Cerebroacrovisceral Early Lethality Complex .
Hall-Pallister Syndrome .
Hypothalamic Hamartoblastoma Syndrome .
Hypothalamic Hamartoblastoma, Hypopituitarism, Imperforate Anus, and Postaxial Polydactyly .
CAVE Complices .
Complex, CAVE .
Complices, CAVE .
Hall Pallister Syndrome .
Hamartoblastoma Syndrome, Hypothalamic .
Hamartoblastoma Syndromes, Hypothalamic .
Hypothalamic Hamartoblastoma Syndromes .
Pallister Hall Syndrome .
Syndrome, Hall-Pallister .
Syndrome, Hypothalamic Hamartoblastoma .
Syndrome, Pallister-Hall .
Syndromes, Hypothalamic Hamartoblastoma .
A pleiotropic disorder of human development that comprises hypothalamic HAMARTOMA; central and postaxial POLYDACTYLY; bifid EPIGLOTTIS; ANAL ATRESIA; and renal and other abnormalities. This disorder is associated with FRAMESHIFT MUTATIONS in the GLI3 gene which encodes the GLI3 protein, a KRUPPEL-LIKE TRANSCRIPTION FACTORS family member. .